CRISPR-Cas12a-Based Electrochemical Biosensor for Rapid Detection of African Swine Fever Virus in Blood Samples

Introduction

African swine fever virus (ASFV) is a large, enveloped double-stranded DNA virus belonging to the family Asfarviridae and is the causative agent of African swine fever, a highly contagious and often fatal hemorrhagic disease of domestic pigs and wild boar [1]. The virus exhibits remarkable genetic diversity with multiple genotypes circulating globally, and no licensed vaccine or antiviral treatment is currently available, making rapid and accurate diagnosis a cornerstone of outbreak control [2]. Conventional detection methods include quantitative real-time PCR (qPCR), virus isolation, and antigen-capture enzyme-linked immunosorbent assays [3]. While qPCR remains the gold standard for sensitivity and specificity, it requires expensive thermocycling equipment, skilled personnel, and sample transport to centralized laboratories, which delays result availability [4]. This limitation has spurred interest in point-of-care molecular diagnostics that combine isothermal amplification with CRISPR-Cas enzymatic systems to generate a detectable signal without thermal cycling [5, 6].

CRISPR-Cas12a (formerly known as Cpf1) is an RNA-guided endonuclease that, upon specific recognition of a double-stranded DNA target, activates a non-specific single-stranded DNase (trans-cleavage) activity [7]. This property has been harnessed for nucleic acid detection where the collateral cleavage of reporter molecules translates the presence of a target sequence into a measurable signal [8]. Electrochemical biosensors, in particular, offer advantages in portability, quantitative readout, low power consumption, and compatibility with miniaturized electronics [9]. Integration of CRISPR-Cas12a with an electrochemical transducer can produce a sensitive, specific, and rapid assay for ASFV DNA in porcine blood samples [10]. This article provides a detailed technical review of such a platform, examining the molecular mechanism, electrode design, assay optimization, and performance characteristics relative to existing methods.

Mechanism of CRISPR-Cas12a Recognition and Trans-Cleavage

The Cas12a effector protein is guided by a CRISPR RNA (crRNA) that contains a 20-24 nucleotide spacer sequence complementary to the target DNA [11]. Upon binding to the protospacer adjacent motif (PAM) on the target strand, Cas12a undergoes a conformational change that positions the target strand for site-specific cleavage [7]. Following recognition and cleavage of the target, the RuvC nuclease domain of Cas12a becomes constitutively active, capable of non-specifically cleaving single-stranded DNA (ssDNA) molecules in solution [8]. This trans-cleavage rate is orders of magnitude higher than the initial cis-cleavage and proceeds as long as the target remains bound [11].

In the context of ASFV detection, the crRNA is designed to target a conserved region of the viral genome, such as the B646L gene encoding the major capsid protein p72 [1, 12]. The B646L gene is present in all known ASFV genotypes and is the standard target for PCR-based diagnostics [13]. Sequences are carefully selected to avoid cross-reactivity with swine genomic DNA or with other porcine viruses [14]. The spacer length and GC content are optimized for Cas12a affinity; typical spacer lengths range from 20 to 22 nucleotides with a PAM sequence (5'-TTTV-3') immediately upstream of the target [7, 11].

Once the Cas12a-crRNA complex (ribonucleoprotein) encounters target ASFV DNA, the trans-cleavage activity degrades any ssDNA reporter probes present in the reaction [8]. In an electrochemical biosensor, these reporter probes are typically short ssDNA oligonucleotides that are immobilized on the electrode surface and labeled with an electrochemical reporter molecule (e.g., methylene blue or ferrocene) on the distal end [15]. Cleavage of the probe by Cas12a removes the reporter from the electrode surface or alters the distance between the reporter and the electrode, causing a change in current that is measured via amperometry or electrochemical impedance spectroscopy [9].

Electrochemical Readout and Electrode Design

The working electrode is typically a gold disk or screen-printed gold electrode modified with a self-assembled monolayer (SAM) of thiolated ssDNA capture probes [15]. The general structure is:

1. Gold electrode surface.
2. SAM of a short spacer thiol (e.g., 6-mercapto-1-hexanol) to reduce non-specific adsorption.
3. Dual-labeled reporter ssDNA probe with a thiol at the 5' end for immobilization and a redox label (e.g., methylene blue) at the 3' end.
4. The probe is designed to be fully cleavable by Cas12a upon activation; a sequence such as poly-T or random bases can be used [8].

In the absence of target ASFV DNA, Cas12a remains in an inactive state and the reporter probes remain intact on the surface [11]. When a potential sweep is applied, the redox label undergoes faradaic electron transfer, generating a measurable current [15]. The magnitude of the current is proportional to the density of intact probes on the surface.

Upon introduction of a sample containing ASFV DNA, activated Cas12a cleaves the immobilized probes, releasing the redox label into solution or leaving a short, non-conducting fragment on the surface [8]. This results in a decrease in the peak current measured by cyclic voltammetry or square-wave voltammetry [9]. The extent of signal reduction is directly correlated with the initial amount of target DNA present, allowing for quantitative analysis [16, 17].

Impedance-based readouts (electrochemical impedance spectroscopy) measure changes in the charge transfer resistance (Rct) at the electrode-solution interface. Cleavage of the probe layer reduces the electron transfer barrier and displaces the redox marker, leading to a measurable decrease in Rct [15]. Both amperometric and impedimetric modalities have been reported for CRISPR-Cas12a sensors [9].

Assay Design and Workflow for Blood Samples

The entire detection workflow consists of three main steps: (1) sample preparation and DNA extraction from whole blood, (2) isothermal amplification of the target region (optional), and (3) Cas12a recognition and electrochemical readout.

Sample Preparation

Whole blood from suspected ASFV-infected pigs contains high concentrations of host genomic DNA, proteins, and cellular debris that can inhibit enzymatic reactions [3]. Rapid DNA extraction methods using alkaline lysis or solid-phase silica columns are commonly employed [18]. Alternatively, direct lysis of blood cells with proteinase K and heating can release viral DNA with minimal purification [19]. The extracted DNA is resuspended in a low-volume buffer to maintain sufficient viral copy numbers for detection.

Isothermal Amplification

Although Cas12a can theoretically detect attomolar concentrations of DNA, the trans-cleavage signal is typically insufficient for direct detection of clinical samples without target enrichment [8]. Therefore, the target ASFV B646L region is pre-amplified using isothermal methods such as recombinase polymerase amplification (RPA) or loop-mediated isothermal amplification (LAMP) [5, 7]. RPA operates at 37-42°C using a recombinase, single-strand binding proteins, and a strand-displacing polymerase to exponentially amplify DNA within 20-30 minutes [20]. LAMP uses four to six primers and a Bacillus stearothermophilus (Bst) polymerase at 60-65°C [21]. Both methods are compatible with low-resource settings and can be performed in a single tube prior to the Cas12a reaction [5, 6]. After amplification, the Cas12a ribonucleoprotein and reporter probes are added to the same reaction mixture, and electrochemical measurement is performed after a short incubation (typically 5-15 minutes) [8, 9].

Electrochemical Detection

A potentiostat (handheld or benchtop) applies a potential sweep and records the current. The reduction in peak current at the characteristic potential of the redox label (e.g., -0.25 V vs Ag/AgCl for methylene blue) is measured [15]. A threshold decrease of 20% or more relative to the negative control is considered a positive signal [9]. The entire process from blood collection to result can be completed in under one hour, with the electrochemical readout taking only a few seconds [9, 10].

The following mermaid diagram summarizes the workflow:

graph TD
    A[Collect porcine whole blood], > B[Lysis and DNA extraction]
    B, > C[Isothermal amplification (RPA or LAMP) of ASFV B646L target]
    C, > D[Cas12a-crRNA ribonucleoprotein + ssDNA reporter on gold electrode]
    D, > E{Target present?}
    E, >|Yes| F[Cas12a activated: trans-cleavage of reporter]
    E, >|No| G[Cas12a inactive: reporter intact]
    F, > H[Decreased electrochemical signal]
    G, > I[Stable baseline signal]
    H, > J[Measure amperometry / impedance]
    I, > J
    J, > K[Quantitative or qualitative result]

Sensitivity, Specificity, and Comparison with qPCR

The analytical performance of CRISPR-Cas12a electrochemical biosensors for ASFV has been evaluated in multiple studies using spiked blood samples and field specimens [7, 9, 10]. Limits of detection (LOD) typically range from 1 to 10 copies of target DNA per reaction when combined with RPA pre-amplification [5, 8]. This LOD is comparable to that of qPCR, which generally ranges from 1 to 100 copies depending on the assay [3]. However, the electrochemical readout exhibits a dynamic range of approximately 3-4 orders of magnitude, which is narrower than the 6-7 log range of qPCR [9, 16].

Specificity is primarily determined by the crRNA sequence targeting the conserved B646L region [12]. Cross-reactivity testing against other swine viruses such as classical swine fever virus, porcine reproductive and respiratory syndrome virus, and swine influenza A virus has been reported to yield no false-positive signals [7, 10]. Additionally, host genomic DNA from swine blood does not interfere because the crRNA is designed to lack homology to any porcine genome sequences [14].

When validated against qPCR using field samples (whole blood from suspected cases), the electrochemical biosensor has shown diagnostic sensitivity and specificity above 95% and 98%, respectively [9, 10]. Discrepant results often occur in samples with very low viral loads near the LOD, where the isothermal amplification step may yield stochastic results [5]. Table 1 summarizes typical performance metrics.

Table 1. Performance comparison of CRISPR-Cas12a electrochemical biosensor and qPCR for ASFV detection in blood samples.

Challenges in Blood Sample Detection

Whole blood presents several challenges for CRISPR-based diagnostics. The primary issue is the high background of host DNA, which can compete for primers during isothermal amplification and reduce amplification efficiency of the viral target [18]. Although the crRNA is specific to ASFV, nonspecific trans-cleavage can be triggered by off-target binding if the sample contains unintended double-stranded DNA that fortuitously matches the crRNA sequence or if there is primer-dimer formation during RPA [20]. This risk is mitigated by careful primer and crRNA design and by including a digestion step (e.g., using DNase I on non-amplified samples) to remove host DNA before amplification [19].

Another challenge is the inhibition of Cas12a activity by components of the blood lysis solution, such as high concentrations of EDTA, proteinase K, or chaotropic salts [18]. Buffer optimization or the use of a simple boiling lysis method can address this issue [19]. Additionally, the stability of the gold electrode and the SAM layer may be compromised by nucleases present in blood, leading to signal drift [15]. Coating the electrode with a protective layer of bovine serum albumin or using a polyethylene glycol blocker can improve stability [9].

The requirement for an isothermal amplification step adds complexity to the point-of-care integration, as it requires the user to handle liquid reagents and heat to a precise temperature (37-65°C) [5, 21]. Self-contained microfluidic cartridges that combine blood filtration, lysis, amplification, and Cas12a reaction are under development to create a fully integrated "sample-to-answer" device [6, 10].

Future Directions: Multiplexing and Point-of-Care Integration

To enhance the utility of the electrochemical biosensor, two major areas are being explored: multiplex detection of multiple ASFV genotypes or other swine pathogens, and integration into portable devices for field deployment [9].

Multiplexing

Multiplexing can be achieved by using multiple working electrodes on a single chip, each modified with a distinct crRNA targeting different ASFV genes or different viruses [17]. For example, a panel could include crRNAs for ASFV B646L (p72), CP204L (p30), and EP402R (CD2v) to simultaneously discriminate between genotypes or vaccine strains [12]. Alternatively, using different redox labels (e.g., methylene blue, ferrocene, anthraquinone) on separate reporter probes allows spatial or potential-mediated multiplexing on a single electrode [15]. The electrochemical readout can resolve signals from multiple labels in the same scan, enabling the detection of up to three targets per electrode [17].

Multiplexing also allows internal positive controls, such as a synthetic DNA target spiked into the sample, to monitor for inhibition [4]. This is critical for decentralized testing where sample quality cannot be guaranteed.

Point-of-Care Integration

Handheld potentiostats with Bluetooth connectivity are now commercially available and can be paired with disposable screen-printed electrodes [9]. The entire assay can be performed on a single microfluidic chip that integrates blood separation, lysis, isothermal amplification, and electrochemical detection [6, 10]. Such chips are fabricated from polymer materials (e.g., cyclic olefin copolymer) and incorporate valves, pumps, and heating elements controlled by a smartphone app [6]. Field trials of integrated devices for ASFV detection have demonstrated concordance with qPCR above 90% [10].

The elimination of cold-chain reagent storage is another goal. Lyophilized Cas12a-crRNA RNPs remain active for weeks at ambient temperature, and air-dried amplification reagents can be rehydrated on chip [8]. This makes the platform suitable for surveillance in remote areas where ASFV is endemic [2].

Links to Related Diagnostics and Viral Knowledge

The electrochemical sensor discussed here builds on a broader ecosystem of CRISPR-based diagnostics for veterinary viruses. Numerous articles on this portal describe parallel developments, including a lateral flow version of the Cas12a assay [5] and a microfluidic integrated device [6]. The fundamental principles of Cas12a detection are also applied to canine distemper virus and porcine reproductive and respiratory syndrome virus [7, 14]. For detailed background on the pathogen itself, refer to the main ASFV pathogen article [1] and computational models for spread prediction [2]. The use of isothermal amplification prior to Cas12a recognition is directly analogous to LAMP-based assays for ASFV in oral fluids [21] and digital PCR quantification [4]. Each of these modalities contributes to an expanding diagnostic toolkit for swine health management.

Conclusion

The CRISPR-Cas12a-based electrochemical biosensor represents a powerful tool for rapid, sensitive detection of African swine fever virus in blood samples. By combining the precise nucleic acid recognition of Cas12a with the quantitative electrochemical transduction on a gold electrode, this platform achieves limits of detection comparable to qPCR in under one hour. Its isothermal nature and simple instrumentation make it suitable for point-of-care deployment in resource-limited settings. Challenges related to sample preparation, host DNA interference, and assay robustness are being addressed through integrated microfluidic design and lyophilized reagent formulation. Future multiplexed versions will enable simultaneous detection of multiple ASFV genotypes and coinfecting pathogens, further strengthening early warning systems for swine health.

Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.

References

[1] African Swine Fever Virus. /knowledge/viruses/livestock-viruses/african-swine-fever-virus

[2] African Swine Fever: Computational Models for Early Detection and Spread Prediction in Wild Boar Populations. /knowledge/bioinformatics/african-swine-fever-computational-models-for-early-detection-and-spread-prediction-in-wild-boar-populations

[3] Development and Validation of a CRISPR-Cas12a-Based Diagnostic Assay for Rapid Detection of African Swine Fever Virus in Porcine Samples. /knowledge/diagnostics/crispr-cas12a-diagnostic-assay-african-swine-fever-virus-porcine

[4] Development and Evaluation of a Digital PCR Assay for the Detection of African Swine Fever Virus in Oral Fluids. /knowledge/diagnostics/digital-pcr-african-swine-fever-virus-oral-fluids

[5] CRISPR Cas12a Based Lateral Flow Assay for Rapid Point of Care Detection of African Swine Fever Virus in Porcine Blood and Oral Fluids. /knowledge/diagnostics/crispr-cas12a-lateral-flow-assay-african-swine-fever-virus-porcine

[6] CRISPR-based point-of-care diagnostics for African swine fever virus: From Cas12a detection to integrated microfluidic devices. /knowledge/diagnostics/crispr-point-of-care-african-swine-fever-detection

[7] CRISPR-Cas12a Based Biosensor for Rapid Detection of African Swine Fever Virus in Porcine Blood. /knowledge/diagnostics/crispr-cas12a-biosensor-african-swine-fever-porcine-blood

[8] CRISPR-Cas12a-Based Biosensor for Rapid Detection of African Swine Fever Virus: From Assay Design to Field Deployment. /knowledge/diagnostics/crispr-cas12a-biosensor-african-swine-fever-virus-detection

[9] CRISPR-Cas12a-Based Diagnostics for Rapid Detection of African Swine Fever Virus in Field Samples. /knowledge/diagnostics/crispr-cas12a-based-diagnostics-african-swine-fever

[10] CRISPR-Cas12a Based Detection of African Swine Fever Virus: A Point-of-Care Molecular Assay for Field Surveillance. /knowledge/diagnostics/crispr-cas12a-detection-african-swine-fever-virus-point-of-care

[11] CRISPR-Cas12a and Cas13a Platforms for Rapid Veterinary Viral Diagnostics. /knowledge/diagnostics/crispr-cas12a-cas13a-rapid-veterinary-viral-diagnostics

[12] Structural and Computational Analysis of African Swine Fever Virus Capsid Proteins for Antiviral Drug Design. /knowledge/bioinformatics/structural-computational-analysis-asfv-capsid-antiviral-drug-design

[13] Loop-Mediated Isothermal Amplification (LAMP) Assay for Rapid Detection of African Swine Fever Virus in Oral Fluids. /knowledge/diagnostics/lamp-assay-rapid-detection-african-swine-fever-virus-oral-fluids

[14] CRISPR-Cas13-Based Direct Detection of Porcine Reproductive and Respiratory Syndrome Virus in Oral Fluids: A Field-Deployable Molecular Platform. /knowledge/diagnostics/crispr-cas13-direct-detection-porcine-reproductive-respiratory-syndrome-virus-oral-fluids-field-deployable-molecular-platform

[15] Electrochemical Sensors for Real-Time Veterinary Pathogen Monitoring. /knowledge/diagnostics/electrochemical-sensors-for-real-time-veterinary-pathogen-monitoring

[16] Biosensors and Point-of-Care (POC) Veterinary Diagnostics. /knowledge/diagnostics/biosensors-and-point-of-care

[17] Nanotechnology in Rapid Viral Diagnostic Tests. /knowledge/diagnostics/nanotechnology-in-rapid-viral-diagnostic-tests

[18] Hematology, CBC, and Blood Smear Interpretation. /knowledge/diagnostics/hematology-cbc-blood-smear

[19] Loop-Mediated Isothermal Amplification for Rapid Point-of-Care Detection of Canine Distemper Virus in Field Samples. /knowledge/diagnostics/loop-mediated-isothermal-amplification-canine-distemper-virus-field-samples

[20] Recombinase Polymerase Amplification (RPA) for Field Detection of Rabies Virus in Saliva Samples. /knowledge/diagnostics/recombinase-polymerase-amplification-rabies-saliva-detection

[21] Loop-Mediated Isothermal Amplification (LAMP) for Point-of-Care Detection of Feline Immunodeficiency Virus (FIV) in Blood Samples. /knowledge/diagnostics/lamp-point-of-care-detection-feline-immunodeficiency-virus